Use of Levosimendan in Patients With Low Left Ventricular Ejection Fraction in Ordu/Turkey: Report of Experience with Mini Review
Mihriban Yalcin, Eda Godekmerdan, Kaptanı Derya Tayfur, Serkan Yazman, Ahmet Ozyazicioglu
Cardiology and Angiology: An International Journal · pp. 1–8 · Published 10 Jun 2017
10.9734/CA/2017/33415Abstract
Aims:To report the effect of prophylactic usage of levosimendan in patients with low left ventricular ejection fraction undergoing coronary artery bypass grafting (CABG). Methods: We reported early results of 32 patients (26 male and 6 female; mean age 61.630 ± 9.653 years) who received preoperative levosimendan who underwent CABG with left ventricular ejection fraction (LVEF) of 35% or less between March 2014 and August 2016. Results: All patients achieved to wean from cardiopulmonary bypass. In only four patients there was a need for intraaortic baloon pump (12.5%). Mortality was in 4 patients (12.5%). And six months after the operation all patients (discharged from hospital) were alive. Conclusion: Preoperatively administration of the long-acting inotrope levosimendan might be feasible and have a favourable safety profile in patients with severely reduced LVEF undergoing CABG. We suggest that levosimendan may be useful in high-risk CABG patients.
References (21)
- 1 Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery [DOI]
- 2 Sustained Hemodynamic Effects of Intravenous Levosimendan [DOI]
- 3 The Effects of Levosimendan in Cardiac Surgery Patients with Poor Left Ventricular Function [DOI]
- 4 Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass.
- 5 Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion [DOI]
- 6 Levosimendan for Prevention of Acute Kidney Injury After Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials [DOI]
- 7 Effects of Intravenous Levosimendan on Human Coronary Vasomotor Regulation, Left Ventricular Wall Stress, and Myocardial Oxygen Uptake [DOI]
- 8 Preconditioning effects of levosimendan in coronary artery bypass grafting—a pilot study [DOI]
- 9 Levosimendan in Cardiac Surgery: Current Best Available Evidence [DOI]
- 10 Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlled trials [DOI]
- 11 Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery [DOI]
- 12 Levosimendan Reduces Mortality in Adults with Left Ventricular Dysfunction Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis [DOI]
- 13 Perioperative Use of Levosimendan: Best Practice in Operative Settings [DOI]
- 14 Multiple signalling pathways underlie the protective effect of levosimendan in cardiac myocytes [DOI]
- 15 Novel biologic mechanisms of levosimendan and its effect on the failing heart [DOI]
- 16 Apoptosis: Pathophysiology and therapeutic implications for the cardiac surgeon [DOI]
- 17 Value of Prolonged QRS Duration as a Predictor of Low Cardiac Output Syndrome in Patients With Impaired Left Ventricular Systolic Function Who Undergo Isolated Coronary Artery Bypass Grafting [DOI]
- 18 Levosimendan Increases Bleeding Risk After Heart Valve Surgery: A Retrospective Analysis of a Randomized Trial [DOI]
- 19 Preoperative usages of levosimendan in patients undergoing coronary artery bypass grafting.
- 20 LEVOSIMENDAN: A NEW DUAL‐ACTION DRUG IN THE TREATMENT OF ACUTE HEART FAILURE [DOI]
- 21 Effects of levosimendan in cardiac surgery patients with poor left ventricular function [DOI]
Cited by 0
No indexed citations yet.
Article metrics
Real usage data collected on this platform.
50
Page views
0
PDF downloads
26
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.